UniProt ID | PRP31_HUMAN | |
---|---|---|
UniProt AC | Q8WWY3 | |
Protein Name | U4/U6 small nuclear ribonucleoprotein Prp31 | |
Gene Name | PRPF31 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 499 | |
Subcellular Localization | Nucleus . Nucleus speckle . Nucleus, Cajal body . Predominantly found in speckles and in Cajal bodies. | |
Protein Description | Involved in pre-mRNA splicing as component of the spliceosome. [PubMed: 11867543] | |
Protein Sequence | MSLADELLADLEEAAEEEEGGSYGEEEEEPAIEDVQEETQLDLSGDSVKTIAKLWDSKMFAEIMMKIEEYISKQAKASEVMGPVEAAPEYRVIVDANNLTVEIENELNIIHKFIRDKYSKRFPELESLVPNALDYIRTVKELGNSLDKCKNNENLQQILTNATIMVVSVTASTTQGQQLSEEELERLEEACDMALELNASKHRIYEYVESRMSFIAPNLSIIIGASTAAKIMGVAGGLTNLSKMPACNIMLLGAQRKTLSGFSSTSVLPHTGYIYHSDIVQSLPPDLRRKAARLVAAKCTLAARVDSFHESTEGKVGYELKDEIERKFDKWQEPPPVKQVKPLPAPLDGQRKKRGGRRYRKMKERLGLTEIRKQANRMSFGEIEEDAYQEDLGFSLGHLGKSGSGRVRQTQVNEATKARISKTLQRTLQKQSVVYGGKSTIRDRSSGTASSVAFTPLQGLEIVNPQAAEKKVAEANQKYFSSMAEFLKVKGEKSGLMST | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSLADELLA ------CCHHHHHHH | 32.06 | 28464451 | |
23 | Phosphorylation | EEEEGGSYGEEEEEP HHHCCCCCCCCCCCC | 31.65 | 28464451 | |
53 | 2-Hydroxyisobutyrylation | DSVKTIAKLWDSKMF CHHHHHHHHHCCHHH | 46.38 | - | |
53 | Ubiquitination | DSVKTIAKLWDSKMF CHHHHHHHHHCCHHH | 46.38 | - | |
58 | Ubiquitination | IAKLWDSKMFAEIMM HHHHHCCHHHHHHHH | 35.25 | 32015554 | |
70 | Phosphorylation | IMMKIEEYISKQAKA HHHHHHHHHHHHCHH | 9.56 | - | |
73 | Ubiquitination | KIEEYISKQAKASEV HHHHHHHHHCHHHHH | 44.72 | 27667366 | |
73 | Acetylation | KIEEYISKQAKASEV HHHHHHHHHCHHHHH | 44.72 | 25953088 | |
76 | Ubiquitination | EYISKQAKASEVMGP HHHHHHCHHHHHCCC | 50.37 | - | |
81 | Sulfoxidation | QAKASEVMGPVEAAP HCHHHHHCCCCCCCC | 4.39 | 21406390 | |
90 | Phosphorylation | PVEAAPEYRVIVDAN CCCCCCCEEEEEECC | 14.77 | - | |
140 | Ubiquitination | LDYIRTVKELGNSLD HHHHHHHHHHHHHHH | 46.76 | 29967540 | |
140 | 2-Hydroxyisobutyrylation | LDYIRTVKELGNSLD HHHHHHHHHHHHHHH | 46.76 | - | |
145 | Phosphorylation | TVKELGNSLDKCKNN HHHHHHHHHHHHCCC | 35.83 | 27067055 | |
148 | Ubiquitination | ELGNSLDKCKNNENL HHHHHHHHHCCCHHH | 53.02 | 29967540 | |
201 | Ubiquitination | ALELNASKHRIYEYV HHHHCCCHHHHHHHH | 34.20 | 29901268 | |
205 | Phosphorylation | NASKHRIYEYVESRM CCCHHHHHHHHHHHH | 10.93 | 27273156 | |
207 | Phosphorylation | SKHRIYEYVESRMSF CHHHHHHHHHHHHCH | 7.79 | 28152594 | |
210 | Phosphorylation | RIYEYVESRMSFIAP HHHHHHHHHHCHHCC | 24.20 | 28152594 | |
239 | Phosphorylation | MGVAGGLTNLSKMPA HCHHCCCCCHHCCCC | 37.07 | 21406692 | |
242 | Phosphorylation | AGGLTNLSKMPACNI HCCCCCHHCCCCCCE | 29.04 | 21406692 | |
273 | Phosphorylation | SVLPHTGYIYHSDIV CCCCCCCEEECHHHH | 10.24 | 17360941 | |
275 | Phosphorylation | LPHTGYIYHSDIVQS CCCCCEEECHHHHHH | 6.18 | 22817900 | |
298 | Ubiquitination | AARLVAAKCTLAARV HHHHHHHHHHHHHCC | 20.29 | - | |
298 | Sumoylation | AARLVAAKCTLAARV HHHHHHHHHHHHHCC | 20.29 | - | |
298 | Ubiquitination | AARLVAAKCTLAARV HHHHHHHHHHHHHCC | 20.29 | 29967540 | |
298 | Acetylation | AARLVAAKCTLAARV HHHHHHHHHHHHHCC | 20.29 | 25953088 | |
298 | Sumoylation | AARLVAAKCTLAARV HHHHHHHHHHHHHCC | 20.29 | - | |
307 | Phosphorylation | TLAARVDSFHESTEG HHHHCCCCCHHCCCC | 26.16 | 29507054 | |
321 | Ubiquitination | GKVGYELKDEIERKF CCCCCCCHHHHHHHH | 41.18 | 29967540 | |
321 | Ubiquitination | GKVGYELKDEIERKF CCCCCCCHHHHHHHH | 41.18 | - | |
321 | Sumoylation | GKVGYELKDEIERKF CCCCCCCHHHHHHHH | 41.18 | - | |
321 | Sumoylation | GKVGYELKDEIERKF CCCCCCCHHHHHHHH | 41.18 | - | |
327 | Sumoylation | LKDEIERKFDKWQEP CHHHHHHHHCCCCCC | 45.16 | - | |
327 | Sumoylation | LKDEIERKFDKWQEP CHHHHHHHHCCCCCC | 45.16 | - | |
330 | Ubiquitination | EIERKFDKWQEPPPV HHHHHHCCCCCCCCC | 54.64 | 29967540 | |
338 | Ubiquitination | WQEPPPVKQVKPLPA CCCCCCCCCCCCCCC | 55.96 | 33845483 | |
338 | Sumoylation | WQEPPPVKQVKPLPA CCCCCCCCCCCCCCC | 55.96 | - | |
338 | Sumoylation | WQEPPPVKQVKPLPA CCCCCCCCCCCCCCC | 55.96 | - | |
341 | Acetylation | PPPVKQVKPLPAPLD CCCCCCCCCCCCCCC | 38.04 | 23236377 | |
341 | Acetylation | PPPVKQVKPLPAPLD CCCCCCCCCCCCCCC | 38.04 | - | |
369 | Phosphorylation | MKERLGLTEIRKQAN HHHHHCCHHHHHHHH | 27.80 | 28555341 | |
379 | Phosphorylation | RKQANRMSFGEIEED HHHHHHCCCHHCCCH | 27.19 | 21712546 | |
388 | Phosphorylation | GEIEEDAYQEDLGFS HHCCCHHHHHHHCCC | 25.42 | 28674151 | |
395 | Phosphorylation | YQEDLGFSLGHLGKS HHHHHCCCHHHCCCC | 31.48 | 26074081 | |
401 | Ubiquitination | FSLGHLGKSGSGRVR CCHHHCCCCCCCCCC | 58.99 | 32015554 | |
402 | Phosphorylation | SLGHLGKSGSGRVRQ CHHHCCCCCCCCCCH | 36.07 | 26074081 | |
404 | Phosphorylation | GHLGKSGSGRVRQTQ HHCCCCCCCCCCHHH | 30.43 | 26074081 | |
410 | Phosphorylation | GSGRVRQTQVNEATK CCCCCCHHHHHHHHH | 24.74 | 26074081 | |
416 | Phosphorylation | QTQVNEATKARISKT HHHHHHHHHHHHHHH | 21.03 | 21406692 | |
417 | Ubiquitination | TQVNEATKARISKTL HHHHHHHHHHHHHHH | 42.59 | - | |
417 | Sumoylation | TQVNEATKARISKTL HHHHHHHHHHHHHHH | 42.59 | - | |
417 (in isoform 1) | Ubiquitination | - | 42.59 | 21890473 | |
417 | Sumoylation | TQVNEATKARISKTL HHHHHHHHHHHHHHH | 42.59 | - | |
417 | Ubiquitination | TQVNEATKARISKTL HHHHHHHHHHHHHHH | 42.59 | 22817900 | |
417 | Acetylation | TQVNEATKARISKTL HHHHHHHHHHHHHHH | 42.59 | 25953088 | |
421 | Phosphorylation | EATKARISKTLQRTL HHHHHHHHHHHHHHH | 17.65 | 22798277 | |
422 | Sumoylation | ATKARISKTLQRTLQ HHHHHHHHHHHHHHH | 51.38 | - | |
422 | Sumoylation | ATKARISKTLQRTLQ HHHHHHHHHHHHHHH | 51.38 | - | |
422 | Ubiquitination | ATKARISKTLQRTLQ HHHHHHHHHHHHHHH | 51.38 | 22817900 | |
423 | Phosphorylation | TKARISKTLQRTLQK HHHHHHHHHHHHHHH | 22.72 | 22798277 | |
430 (in isoform 1) | Ubiquitination | - | 47.88 | 21890473 | |
430 | Sumoylation | TLQRTLQKQSVVYGG HHHHHHHHCCEEECC | 47.88 | - | |
430 | Ubiquitination | TLQRTLQKQSVVYGG HHHHHHHHCCEEECC | 47.88 | 22817900 | |
430 | Ubiquitination | TLQRTLQKQSVVYGG HHHHHHHHCCEEECC | 47.88 | - | |
430 | Sumoylation | TLQRTLQKQSVVYGG HHHHHHHHCCEEECC | 47.88 | - | |
432 | Phosphorylation | QRTLQKQSVVYGGKS HHHHHHCCEEECCCC | 22.15 | 23927012 | |
435 | Phosphorylation | LQKQSVVYGGKSTIR HHHCCEEECCCCEEE | 20.29 | 20164059 | |
438 | Methylation | QSVVYGGKSTIRDRS CCEEECCCCEEECCC | 39.81 | 30591561 | |
438 | Acetylation | QSVVYGGKSTIRDRS CCEEECCCCEEECCC | 39.81 | 25953088 | |
438 | Ubiquitination | QSVVYGGKSTIRDRS CCEEECCCCEEECCC | 39.81 | 32015554 | |
439 | Phosphorylation | SVVYGGKSTIRDRSS CEEECCCCEEECCCC | 32.13 | 23401153 | |
440 | Phosphorylation | VVYGGKSTIRDRSSG EEECCCCEEECCCCC | 24.42 | 23401153 | |
445 | Phosphorylation | KSTIRDRSSGTASSV CCEEECCCCCCCCEE | 37.09 | 23927012 | |
446 | Phosphorylation | STIRDRSSGTASSVA CEEECCCCCCCCEEE | 40.85 | 23927012 | |
448 | Phosphorylation | IRDRSSGTASSVAFT EECCCCCCCCEEEEE | 25.89 | 23927012 | |
450 | Phosphorylation | DRSSGTASSVAFTPL CCCCCCCCEEEEEEC | 25.78 | 23927012 | |
451 | Phosphorylation | RSSGTASSVAFTPLQ CCCCCCCEEEEEECC | 18.27 | 23927012 | |
455 | Phosphorylation | TASSVAFTPLQGLEI CCCEEEEEECCCCEE | 17.22 | 23927012 | |
470 | Acetylation | VNPQAAEKKVAEANQ CCHHHHHHHHHHHHH | 48.06 | 25953088 | |
470 | Ubiquitination | VNPQAAEKKVAEANQ CCHHHHHHHHHHHHH | 48.06 | 32015554 | |
471 | Ubiquitination | NPQAAEKKVAEANQK CHHHHHHHHHHHHHH | 37.88 | - | |
471 | Sumoylation | NPQAAEKKVAEANQK CHHHHHHHHHHHHHH | 37.88 | 28112733 | |
478 (in isoform 1) | Ubiquitination | - | 48.33 | 21890473 | |
478 | Ubiquitination | KVAEANQKYFSSMAE HHHHHHHHHHHHHHH | 48.33 | 22817900 | |
478 | Sumoylation | KVAEANQKYFSSMAE HHHHHHHHHHHHHHH | 48.33 | 28112733 | |
478 | Sumoylation | KVAEANQKYFSSMAE HHHHHHHHHHHHHHH | 48.33 | - | |
478 | Ubiquitination | KVAEANQKYFSSMAE HHHHHHHHHHHHHHH | 48.33 | - | |
479 | Phosphorylation | VAEANQKYFSSMAEF HHHHHHHHHHHHHHH | 10.03 | 20068231 | |
481 | Phosphorylation | EANQKYFSSMAEFLK HHHHHHHHHHHHHHH | 19.00 | 20068231 | |
482 | Phosphorylation | ANQKYFSSMAEFLKV HHHHHHHHHHHHHHH | 16.47 | 20068231 | |
488 | Ubiquitination | SSMAEFLKVKGEKSG HHHHHHHHHHCCCCC | 47.42 | 32015554 | |
490 | Ubiquitination | MAEFLKVKGEKSGLM HHHHHHHHCCCCCCC | 60.82 | - | |
493 | Ubiquitination | FLKVKGEKSGLMST- HHHHHCCCCCCCCC- | 59.50 | - | |
494 | Phosphorylation | LKVKGEKSGLMST-- HHHHCCCCCCCCC-- | 32.62 | 24732914 | |
498 | Phosphorylation | GEKSGLMST------ CCCCCCCCC------ | 35.69 | 24732914 | |
499 | Phosphorylation | EKSGLMST------- CCCCCCCC------- | 28.76 | 24732914 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PRP31_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRP31_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRP31_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
600138 | Retinitis pigmentosa 11 (RP11) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379 AND THR-455, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-448 AND THR-455, ANDMASS SPECTROMETRY. |